Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2025-12-24 @ 11:08 PM
NCT ID:
NCT05035069
Eligibility Criteria:
Inclusion Criteria:
* Patient scheduled for TAVR through femoral artery access
* 1h ≤ Expected duration of surgery ≤ 3h
* Planned for general anesthesia without intubation
* 18 ≤ BMI ≤ 30
* ASA category Ⅱ～Ⅳ
Exclusion Criteria:
* Contraindications to anesthesia/sedation or a history of adverse reaction to anesthesia/sedation
* Known allergies to eggs, soy products, opioids and their antidotes, propofol, etc; Contraindications of propofol, opioids and their antidotes
* Shock and hypotension difficult that is to be corrected by vasoactive drugs in the screening period
* Hemoglobin (HB) \< 10.0 g / dl (100 g / L)
* Judged by the investigator to have any other factors that make the subject unsuitable for participation in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Maximum Age:
85 Years
Study:
NCT05035069
Study Brief:
Protocol Section:
NCT05035069